Hannah Clark1, Raquel Granell1, John A Curtin2, Danielle Belgrave3, Angela Simpson2, Clare Murray2, A John Henderson1, Adnan Custovic3, Lavinia Paternoster1. 1. MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. 2. Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, and Manchester University NHS Foundation Trust, Manchester, UK. 3. Section of Paediatrics, Department of Medicine, Imperial College London, London, UK.
Abstract
BACKGROUND: Allergic diseases (eczema, wheeze and rhinitis) in children often present as heterogeneous phenotypes. Understanding genetic associations of specific patterns of symptoms might facilitate understanding of the underlying biological mechanisms. OBJECTIVE: To examine associations between allergic disease-related variants identified in a recent genome-wide association study and latent classes of allergic diseases (LCADs) in two population-based birth cohorts. METHODS: Eight previously defined LCADs between birth and 11 years: "No disease," "Atopic march," "Persistent eczema and wheeze," "Persistent eczema with later-onset rhinitis," "Persistent wheeze with later-onset rhinitis," "Transient wheeze," "Eczema only" and "Rhinitis only" were used as the study outcome. Weighted multinomial logistic regression was used to estimate associations between 135 SNPs (and a polygenic risk score, PRS) and LCADs among 6345 individuals from The Avon Longitudinal Study of Parents and Children (ALSPAC). Heterogeneity across LCADs was assessed before and after Bonferroni correction. Results were replicated in Manchester Asthma and Allergy Study (MAAS) (n = 896) and pooled in a meta-analysis. RESULTS: We found strong evidence for differential genetic associations across the LCADs; pooled PRS heterogeneity P-value = 3.3 × 10-14 , excluding "no disease" class. The associations between the PRS and LCADs in MAAS were remarkably similar to ALSPAC. Two SNPs (a protein-truncating variant in FLG and a SNP within an intron of GSDMB) had evidence for differential association (pooled P-values ≤ 0.006). The FLG locus was differentially associated across LCADs that included eczema, with stronger associations for LCADs with comorbid wheeze and rhinitis. The GSDMB locus in contrast was equally associated across LCADs that included wheeze. CONCLUSIONS AND CLINICAL RELEVANCE: We have shown complex, but distinct patterns of genetic associations with LCADs, suggesting that heterogeneous mechanisms underlie individual disease trajectories. Establishing the combination of allergic diseases with which each genetic variant is associated may inform therapeutic development and/or predictive modelling.
BACKGROUND:Allergic diseases (eczema, wheeze and rhinitis) in children often present as heterogeneous phenotypes. Understanding genetic associations of specific patterns of symptoms might facilitate understanding of the underlying biological mechanisms. OBJECTIVE: To examine associations between allergic disease-related variants identified in a recent genome-wide association study and latent classes of allergic diseases (LCADs) in two population-based birth cohorts. METHODS: Eight previously defined LCADs between birth and 11 years: "No disease," "Atopic march," "Persistent eczema and wheeze," "Persistent eczema with later-onset rhinitis," "Persistent wheeze with later-onset rhinitis," "Transient wheeze," "Eczema only" and "Rhinitis only" were used as the study outcome. Weighted multinomial logistic regression was used to estimate associations between 135 SNPs (and a polygenic risk score, PRS) and LCADs among 6345 individuals from The Avon Longitudinal Study of Parents and Children (ALSPAC). Heterogeneity across LCADs was assessed before and after Bonferroni correction. Results were replicated in Manchester Asthma and Allergy Study (MAAS) (n = 896) and pooled in a meta-analysis. RESULTS: We found strong evidence for differential genetic associations across the LCADs; pooled PRS heterogeneity P-value = 3.3 × 10-14 , excluding "no disease" class. The associations between the PRS and LCADs in MAAS were remarkably similar to ALSPAC. Two SNPs (a protein-truncating variant in FLG and a SNP within an intron of GSDMB) had evidence for differential association (pooled P-values ≤ 0.006). The FLG locus was differentially associated across LCADs that included eczema, with stronger associations for LCADs with comorbid wheeze and rhinitis. The GSDMB locus in contrast was equally associated across LCADs that included wheeze. CONCLUSIONS AND CLINICAL RELEVANCE: We have shown complex, but distinct patterns of genetic associations with LCADs, suggesting that heterogeneous mechanisms underlie individual disease trajectories. Establishing the combination of allergic diseases with which each genetic variant is associated may inform therapeutic development and/or predictive modelling.
Authors: Youming Zhang; Saffron A G Willis-Owen; Sarah Spiegel; Clare M Lloyd; Miriam F Moffatt; William O C M Cookson Journal: Am J Respir Crit Care Med Date: 2019-02-15 Impact factor: 21.405
Authors: Bryan Howie; Christian Fuchsberger; Matthew Stephens; Jonathan Marchini; Gonçalo R Abecasis Journal: Nat Genet Date: 2012-07-22 Impact factor: 38.330
Authors: Danielle C M Belgrave; Iain Buchan; Christopher Bishop; Lesley Lowe; Angela Simpson; Adnan Custovic Journal: Am J Respir Crit Care Med Date: 2014-05-01 Impact factor: 21.405
Authors: Mattia C F Prosperi; Umit M Sahiner; Danielle Belgrave; Cansin Sackesen; Iain E Buchan; Angela Simpson; Tolga S Yavuz; Omer Kalayci; Adnan Custovic Journal: Am J Respir Crit Care Med Date: 2013-12-01 Impact factor: 21.405
Authors: Raquel Granell; A John Henderson; Nicholas Timpson; Beate St Pourcain; John P Kemp; Susan M Ring; Karen Ho; Stephen B Montgomery; Emmanouil T Dermitzakis; David M Evans; Jonathan A C Sterne Journal: J Allergy Clin Immunol Date: 2012-11-13 Impact factor: 10.793
Authors: Sarah C Glover; Melody C Carter; Peter Korošec; Patrizia Bonadonna; Lawrence B Schwartz; Joshua D Milner; George H Caughey; Dean D Metcalfe; Jonathan J Lyons Journal: Ann Allergy Asthma Immunol Date: 2021-08-13 Impact factor: 6.248
Authors: Anu Laulajainen-Hongisto; Annina Lyly; Paula Kauppi; Sanna Toppila-Salmi; Tanzeela Hanif; Kishor Dhaygude; Matti Kankainen; Risto Renkonen; Kati Donner; Pirkko Mattila; Tuomas Jartti; Jean Bousquet Journal: Clin Transl Allergy Date: 2020-10-28 Impact factor: 5.871
Authors: Christopher H Arehart; Michelle Daya; Monica Campbell; Meher Preethi Boorgula; Nicholas Rafaels; Sameer Chavan; Gloria David; Jon Hanifin; Mark K Slifka; Richard L Gallo; Tissa Hata; Lynda C Schneider; Amy S Paller; Peck Y Ong; Jonathan M Spergel; Emma Guttman-Yassky; Donald Y M Leung; Lisa A Beck; Christopher R Gignoux; Rasika A Mathias; Kathleen C Barnes Journal: J Allergy Clin Immunol Date: 2021-06-07 Impact factor: 10.793
Authors: Dilini M Kothalawala; Latha Kadalayil; John A Curtin; Clare S Murray; Angela Simpson; Adnan Custovic; William J Tapper; S Hasan Arshad; Faisal I Rezwan; John W Holloway Journal: J Pers Med Date: 2022-01-08